Sfoglia per Autore
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis
2004-01-01 MELI M; TOLOMEO M; D'ALESSANDRO N; GRIMAUDO S; NOTARBARTOLO M; PAPOFF G; RUBERTI G; RAUSA L; DUSONCHET L
Expression of the IAPs in multidrug resistant tumor cells
2004-01-01 NOTARBARTOLO M; CERVELLO M; POMA P; DUSONCHET L; MELI M; D'ALESSANDRO N
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells
2004-01-01 NOTARBARTOLO DI VILLAROSA, M; CERVELLO, M; GIANNITRAPANI, L; MELI, M; POMA, P; DUSONCHET, L; MONTALTO, G; D'ALESSANDRO, N
Cytotoxic and apoptotic effects of thiophenfurin in combination with retinoids in human promyelocitic leucemia HL60 cells
2005-01-01 M MELI; M TOLOMEO; M GRIFANTINI; PFRANCHETTI; L CAPPELLACCI; D SIMONI; FP INVIDIATA; DUSONCHET L
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines
2005-01-01 SIMONI D; GRISOLIA G; GIANNINI G; ROBERTI M; RONDANIN R; PICCAGLI L; BARUCHELLO R; ROSSI M; ROMAGNOLI R; INVIDIATA FP; GRIMAUDO S; JUNG MK; HAMEL E; GEBBIA N; CROSTA L; ABBADESSA V; DI CRISTINA A; DUSONCHET L; MELI M; TOLOMEO M
Chemioterapici antibatterici
2005-01-01 D'ALESSANDRO N; DUSONCHET L
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells
2005-01-01 TOLOMEO M; GRIMAUDO S; DI CRISTINA A; ROBERTI M; PIZZIRANI D; MELI M; DUSONCHET L; GEBBIA N; ABBADESSA V; CROSTA L; BARUCHELLO R; GRISOLIA G; INVIDIATA FP; SIMONI D
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells.
2007-01-01 MELI M; TOLOMEO M; GRIFANTINI M; FRANCHETTI P; CAPPELLACCI L; SIMONI D; INVIDIATA FP; AIELLO S; DUSONCHET L
Antitumor profile of new phenothiazine derivatives.
2007-01-01 A BISI; MELI M; S GOBBI; A RAMPA; M TOLOMEO; L DUSONCHET
Hydroxamic acid-containing histone deacetylase inhibitors potentiate the antiproliferative and apoptotic effects induced by the ribonucleotide reductase R1 inhibitor 3'-C-methyl-adenosine in promyelocytic leukemia cell lines
2008-01-01 GRIFANTINI M; CAPPELLACCI L; FRANCHETTI P; MAI A; ROTILI D; VALENTE S; MELI M; TOLOMEO M; DUSONCHET L
Histone deacetylase (HDAC) inhibitors potentiate the antiproliferative and apoptotic effects induced by the novel ribonucleotide reductase (RR) inhibitor 3'-metil-adenosine (3'-Me-Ado) in promyelocitic leukemia cell lines
2008-01-01 MELI M; TOLOMEO M; GRIFANTINI M; MAI A; CAPPELLACCI L; FRANCHETTI P; ROTILI D; VALENTE S; DUSONCHET L
Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives
2008-01-01 BISI, A; MELI, M; GOBBI, S; RAMPA, A; TOLOMEO, M; DUSONCHET, L
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells
2008-01-01 Tolomeo, M; Grimaudo, S; Di Cristina, A; Pipitone, RM; Dusonchet, L; Meli, M; Crosta, L; Gebbia, N; Invidiata, F; Titone Lanza di Scalea, L; Simoni, D
Histone deacetylase (HDAC) inhibition modulates intracellular deoxynucleotides (dNTP) pools and potentiates the antitumor effects of the ribonucleotide reductase (RR) inhibitor 3’-Methyl-adenosine (3’-Me-Ado) in promyelocitic leukaemia cell lines.
2009-01-01 Meli, M; Tolomeo, M; Grifantini, M; Mai, A; Cappellacci, L; Franchetti, P; Saiko, P; Dusonchet, L
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors
2011-01-01 Ferro, A; Cappellacci, L; Mingrino, A; Petrelli, R; Tolomeo, M; Vita, P; D'Alessandro, N; Dusonchet, L; Franchetti, P; Grifantini, M; Meli, M
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3’-C-methyladenosine in leukaemia cells
2011-01-01 Meli, M; Tolomeo, M; Grifantini, M; Mai, A; Cappellacci, L; Petrelli, R; Rotili, D; Ferro, A; Saiko, P; Szekeres, T; Dusonchet, L
Epigenetic agents as an adjunct to active chemotherapy in hematological tumor cell lines
2012-01-01 Ferro, A; Tolomeo, M; Cappellacci, L; Dusonchet, L; Petrelli, R; Franchetti, P; D'Alessandro, N; Grifantini, M; Meli, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile